Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies (Q44971617)

From Wikidata
Jump to navigation Jump to search
scientific article published in August 2004
edit
Language Label Description Also known as
English
Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies
scientific article published in August 2004

    Statements

    Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies (English)
    0 references
    Malladi RK
    Peniket AJ
    Norton AE
    Campbell AJ
    Collins GP
    Eagleton H
    Morgenstern G
    Keen-Mcguire A
    Barnardo M
    Littlewood TJ
    1 August 2004

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit